Prevention of immunosuppressive therapy or chemotherapy-induced reactivation of hepatitis B virus infection: Joint report of the Intractable Liver Diseases Study Group of Japan and the Japanese Study Group of the Standard Antiviral Therapy for Viral Hepatitis
- 1 January 2009
- journal article
- Published by Japan Society of Hepatology in Kanzo
- Vol. 50 (1), 38-42
- https://doi.org/10.2957/kanzo.50.38
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Mortality Secondary to Fulminant Hepatic Failure in Patients with Prior Resolution of Hepatitis B Virus Infection in JapanClinical Infectious Diseases, 2008
- Chronic hepatitis BHepatology, 2007
- Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapyHepatology, 2006
- Occult hepatitis B virus infection in hematopoietic stem cell donors in a hepatitis B virus endemic areaJournal of Hepatology, 2005
- Incidence of hepatitis virus infection and severe liver dysfunction in patients receiving chemotherapy for hematologic malignanciesEuropean Journal of Haematology, 2001
- REVERSE SEROCONVERSION OF HEPATITIS B AFTER ALLOGENEIC BONE MARROW TRANSPLANTATIONTransplantation, 1998
- Persistence of hepatitis B virus DNA in the liver after loss of HBsAg in chronic hepatitis BHepatology, 1993
- Serum and liver hepatitis B virus DNA in chronic hepatitis B after sustained loss of surface antigenGastroenterology, 1992
- Glucocorticoid stimulates hepatitis B viral gene expression in cultured human hepatoma cellsHepatology, 1992
- Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapyGastroenterology, 1991